All Biotech News

List of articles in category All Biotech News
Title	Published Date
RedHill Biopharma Announces Exclusive U.S. Co-Promotion Agreement with Concordia for GI Drug Donnatal®	01/03/2017
New Data Shows that MammaPrint® Substantially Impacts How Breast Cancer Patients in Germany are Treated	12/21/2016
bluebird bio and apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement	12/15/2016
RedHill Biopharma and IntelGenx Announce Definitive Agreement for Commercialization of RIZAPORT® for Migraines with Pharmatronic Co. in South Korea	12/14/2016
Three New Studies Presented at San Antonio Breast Cancer Symposium Further Demonstrate Value of MammaPrint® and BluePrint® in Individualizing Treatment for Breast Cancer Patients	12/14/2016
Acousia Therapeutics Receives EUR 2.5 Million to Develop Innovative Therapy to Treat and Prevent Sensorineural Hearing Loss	12/14/2016
Vetter's Skokie Site Successfully Manufactures Batches on New Clinical Syringe Filling Line	12/13/2016
RedHill Biopharma Announces Positive and Unanimous DSMB Recommendation for Continuation of Phase III Study with RHB-104 for Crohn's Disease	12/13/2016
RedHill Biopharma Announces Phase IIa 48-Week Final Results Further Supporting Potential of RHB-104 in Multiple Sclerosis	12/12/2016
New Flash Cartridges for Peptide Purification from Biotage	12/07/2016
LifeCodexx Receives CE Mark for its Novel NIPT Solution Based On Methylation-Specific Quantitative PCR	12/07/2016
leon-nanodrugs Partners with Instillo for GMP Production of a MicroJet Reactor (MJR®) Based Formulation of a Generic Oncology Supportive Product	12/07/2016
Neurimmune and TVM Capital Life Science Announce Creation of AL-S Pharma to Develop Innovative Therapy for Patients with ALS	12/07/2016
Pfizer Ventures and TVM Life Science Ventures VII Announce Additional Investment in Ixchelsis Ltd.	12/05/2016
Agendia’s MammaPrint® and BluePrint® Tests Highlighted in Multiple Presentations at the 2016 San Antonio Breast Cancer Symposium, Adding Further Clinical Utility	12/02/2016
New Vetter Data Processing Center is Officially Certified	11/30/2016
Orchard Therapeutics Announces Strategic Alliance with Oxford BioMedica	11/29/2016
Orchard Therapeutics and UCLA Receive USD20 Million in Latest Round of Funding from California’s Stem Cell Agency	11/23/2016
RedHill Biopharma Announces YELIVA™ (ABC294640) Poster Presentation at the 2016 EORTC-NCI-AACR Molecular Targets and Cancer Therapeutics Symposium	11/21/2016
Independent Clinical Study Shows Adherium’s Smartinhaler™ Dramatically Improves Clinical Outcomes and Medication Adherence in Children with Asthma	11/17/2016
Zytoprotec Phase II Peritoneal Dialysis Study: Last Patient Out	11/14/2016
Prospective Clinical Follow-Up Study with Over 2,200 Patients Confirms High Test Accuracy of Prenatest® for Fetal Trisomies	11/14/2016
Xellia Pharmaceuticals Commences Packaging and Distribution Operations at Cleveland Site after Successful FDA Inspection	11/14/2016
RedHill Biopharma Reports Positive FDA Type B Meeting on RHB-105 for H. pylori Infection Ahead of Confirmatory Phase III Study	11/10/2016
Sartorius Stedim Biotech Opens New Bioanalytical Testing Laboratory in Boston	11/10/2016
PSR Orphan Experts Launches Patient Organization Advisory Board	11/08/2016
AdAlta Licenses Alzheimer's Disease-Specific Shark Antibodies to Crossbeta Biosciences for Therapeutic and Diagnostic Development	11/08/2016
Agendia’s Proven Breast Cancer Recurrence Assay, MammaPrint, Now Available in the Middle East	11/08/2016
Changes in the AYOXXA Management Team	11/07/2016
AdAlta and XL-protein Announce Collaboration to Develop a Long Acting Version of Its Lead Fibrosis Drug Candidate AD-114 Using PASylation® Technology	11/07/2016

Page 44 of 88